Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03469804
Title Phase II Multicentric Study of Pembrolizumab in Classic or Endemic Kaposi's Sarcoma (KAPKEY)
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors Assistance Publique - Hopitaux de Paris
Indications

Kaposi's sarcoma

Therapies

Pembrolizumab

Age Groups: senior | adult
Covered Countries FRA


No variant requirements are available.